Viracept, created in 2010 (United Kingdom), from 1722 sister brands and 17478 competing brands. The Viracept brand is owned by GSK PLC, a company listed in London. The ISIN, the company's International Securities Identification Number, is GB00BN7SWP63. Viracept is part of the Drug Manufacturers activity sector.